Press release Biocartis Group NV: Biocartis Announces Launch of its Rapid CE-marked IVD Idylla™ GeneFusion Panel for Fast Treatment Decisions in Lung Cancer
20 juin 2022 01h00 HE
|
Biocartis NV
PRESS RELEASE: 20 June 2022, 07:00 CEST Biocartis Announces Launch of its Rapid CE-marked IVD Idylla™ GeneFusion Panel for Fast Treatment Decisions in Lung Cancer Idylla™ GeneFusion Panel available...
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
15 juin 2022 07h30 HE
|
Adaptive Biotechnologies
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Persbericht Biocartis Group NV: Biocartis bereikt belangrijke commerciële mijlpalen: één miljoenste Idylla™ cartridge verkocht en 2.000ste Idylla™ instrument geplaatst
15 juin 2022 01h00 HE
|
Biocartis NV
PERSBERICHT: 15 juni 2022, 07:00 CEST Biocartis bereikt belangrijke commerciële mijlpalen: één miljoenste Idylla™ cartridge verkocht en 2.000ste Idylla™ instrument geplaatst Mechelen, België, 15...
Press release Biocartis Group NV: Biocartis Reaches Key Commercial Milestones: One-Millionth Idylla™ Cartridge Sold and 2,000th Idylla™ Instrument Placed
15 juin 2022 01h00 HE
|
Biocartis NV
PRESS RELEASE: 15 June 2022, 07:00 CEST Biocartis Reaches Key Commercial Milestones: One-Millionth Idylla™ Cartridge Sold and 2,000th Idylla™ Instrument Placed Mechelen, Belgium, 15 June 2022 –...
Asia Cervical Cancer Test (Screening) Market Report 2022: Market will Reach $4.5 Billion by 2027 from $3.6 Billion in 2021
14 juin 2022 04h48 HE
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19" report has been added to...
Keith Meadors Joins Precipio to Lead its Products Division
13 juin 2022 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 13, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company, Precipio, Inc. (NASDAQ: PRPO), today announced that Keith Meadors has joined Precipio as its Senior Vice...
Global Cancer Diagnostics Partnering Deal Terms and Agreements 2015-2022: Access to Over 1000 Deal Records - Company A-Z, Stage of Development, Deal Type, Therapy Focus, and Technology Type
13 juin 2022 04h28 HE
|
Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Diagnostics Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Global Cancer...
Global Diagnostics Partnering Deals Analysis 2015-2022: Analysis of How and Why Companies Enter Diagnostics Partnering Deals
13 juin 2022 04h23 HE
|
Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Global Diagnostics Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Global Diagnostics...
Global Companion Diagnostics Partnering Deal Analysis 2010-2022: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target, Technology Type
13 juin 2022 04h18 HE
|
Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Global Companion Diagnostics Partnering Terms and Agreements 2010-2022" report has been added to ResearchAndMarkets.com's offering. The Global...
Walter P Moore Expands Florida Presence
08 juin 2022 10h11 HE
|
Walter P Moore
Miami, FL, June 08, 2022 (GLOBE NEWSWIRE) -- Global engineering firm Walter P Moore opens its 24th domestic office in Miami, Florida, expanding its presence in South Florida. The Miami office...